Invention Grant
US08354229B2 MiR-25-based methods for the diagnosis and prognosis of acute myeloid leukemia (AML)
有权
基于MiR-25的急性骨髓性白血病（AML）诊断和预后的方法
- Patent Title: MiR-25-based methods for the diagnosis and prognosis of acute myeloid leukemia (AML)
- Patent Title (中): 基于MiR-25的急性骨髓性白血病（AML）诊断和预后的方法
-
Application No.: US13269410Application Date: 2011-10-07
-
Publication No.: US08354229B2Publication Date: 2013-01-15
- Inventor: Carlo M. Croce
- Applicant: Carlo M. Croce
- Applicant Address: US OH Columbus
- Assignee: The Ohio State University Research Foundation
- Current Assignee: The Ohio State University Research Foundation
- Current Assignee Address: US OH Columbus
- Agency: MacMillan, Sobanski & Todd, LLC
- Main IPC: C12Q1/68
- IPC: C12Q1/68
Abstract:
The present invention provides novel methods and compositions for the diagnosis, prognosis and treatment of acute myeloid leukemia (AML). The invention also provides methods of identifying anti-AML agents.
Public/Granted literature
- US20120028833A1 MiR-25-BASED METHODS FOR THE DIAGNOSIS AND PROGNOSIS OF ACUTE MYELOID LEUKEMIA (AML) Public/Granted day:2012-02-02
Information query
